Management of the Axilla in Early-Stage Breast Cancer: Ontario Health (Cancer Care Ontario) and the American Society of Clinical Oncology Joint Guideline
- MeSH Terms
- axilla, breast neoplasms, diagnosis, diagnostic imaging, drug therapy, pathology, physiopathology, radiotherapy, surgery, therapy, radiation effects, cancer, carcinoma, adenocarcinoma, neoplasm, tumour, lymphatic metastasis, lymph nodes, sentinel lymph node biopsy, sentinel lymph node excision, lymphadenectomy, axillary lymph node dissection, antineoplastic agents, therapeutic use, antineoplastic combined chemotherapy protocols, chemoradiotherapy, chemotherapy, adjuvant therapy, neoadjuvant therapy, radioimmunotherapy, radiotherapy, mastectomy, segmental, ultrasonography, mammary, magnetic resonance imaging, positron emission tomography, coloring agent, radiopharmaceutical agent, breast conserving surgery, echomammography
- Guideline Contact
- Fulvia Baldassarre; [email protected]
- Keywords
- axilla, breast neoplasms, breast cancer, diagnosis, sentinel lymph node biopsy, lymphadenectomy
- Date for Review
- In Program in Evidence-Based Care (PEBC), Ontario Health (Cancer Care Ontario), we have an annual review process for each guideline after it is completed. Guidelines are reviewed every fall after they are older than 1 year.
- Publication Date
- 2021-06-07
- Date of Last Evidence Search
- 2020-03-26
- Methods Applied
- Systematic review-based, Externally reviewed, Evidence quality assessment, GRADE approach
- Publication Scope
- Guidelines
- management
- treatment
- Countries of Application
- Canada
- Guideline Publication Status
- Published
- Languages
- English
- Authors
- PEBC (Program in evidenced-based care)
- Publication Year
- 2021